Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Threshold and retreatment parameters of NPe6 photodynamic therapy in retinal and choroidal vessels.

Peyman GA, Kazi AA, Moshfeghi D, Unal M, Khoobehi B, Yoneya S, Mori K, Rivera I.

Ophthalmic Surg Lasers. 2000 Jul-Aug;31(4):323-7.

PMID:
10928670
2.

Photodynamic therapy of experimental choroidal neovascularization with a hydrophilic photosensitizer: mono-L-aspartyl chlorin e6.

Mori K, Yoneya S, Anzail K, Kabasawa S, Sodeyama T, Peyman GA, Moshfeghi DM.

Retina. 2001;21(5):499-508.

PMID:
11642380
3.

Angiographic and histologic effects of fundus photodynamic therapy with a hydrophilic sensitizer (mono-L-aspartyl chlorin e6).

Mori K, Yoneya S, Ohta M, Sano A, Anzai K, Peyman GA, Moshfeghi DM.

Ophthalmology. 1999 Jul;106(7):1384-91.

PMID:
10406627
4.

Threshold power levels for NPe6 photodynamic therapy.

Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi D, Moshfeghi AA.

Ophthalmic Surg Lasers. 2000 Mar-Apr;31(2):136-42.

PMID:
10743925
5.

Retreatment effect of NPe6 photodynamic therapy on the normal primate macula.

Nakashizuka T, Mori K, Hayashi N, Anzail K, Kanail K, Yoneya S, Moshfeghi DM, Peyman GA.

Retina. 2001;21(5):493-8.

PMID:
11642379
6.

Selective occlusion of choroidal neovascularization by photodynamic therapy with a water-soluble photosensitizer, ATX-S10.

Obana A, Gohto Y, Kaneda K, Nakajima S, Takemura T, Miki T.

Lasers Surg Med. 1999;24(3):209-22.

PMID:
10229152
7.

PDT to monkey CNV with ATX-S10(Na): inappropriateness of early laser irradiation for selective occlusion.

Obana A, Gohto Y, Kaneda K, Nakajima S, Miki T.

Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2639-45.

PMID:
11581211
8.

Fluorescence properties of a hydrophilic sensitizer in pigmented rats, rabbits, and monkeys.

Moshfeghi D, Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K.

Ophthalmic Surg Lasers. 1999 Nov-Dec;30(9):750-3.

PMID:
10574497
9.

Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2).

Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, Crean DH.

Ophthalmic Surg Lasers. 1997 May;28(5):409-17.

PMID:
9150524
10.

Problems with and pitfalls of photodynamic therapy.

Peyman GA, Kazi AA, Unal M, Khoobehi B, Yoneya S, Mori K, Moshfeghi DM.

Ophthalmology. 2000 Jan;107(1):29-35.

PMID:
10647715
11.

Retinal and choroidal vessel closure using phthalocyanine photodynamic therapy.

Kliman GH, Puliafito CA, Grossman GA, Gregory WA.

Lasers Surg Med. 1994;15(1):11-8.

PMID:
7997044
12.

Long-term effectiveness of photodynamic therapy by using a hydrophilic photosensitizer ATX-S10(Na) against experimental choroidal neovascularization in rats.

Kanai M, Obana A, Gohto Y, Nagata S, Miki T, Kaneda K, Nakajima S.

Lasers Surg Med. 2000;26(1):48-57.

PMID:
10637003
13.

Photothrombosis of retinal and choroidal vessels in rabbit eyes using chloroaluminum sulfonated phthalocyanine and a diode laser.

Iliaki OE, Naoumidi II, Tsilimbaris MK, Pallikaris IG.

Lasers Surg Med. 1996;19(3):311-23.

PMID:
8923426
14.

Evaluation of the new photosensitizer Tookad (WST09) for photodynamic vessel occlusion of the choroidal tissue in rabbits.

Framme C, Sachs HG, Flucke B, Theisen-Kunde D, Birngruber R.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5437-46.

PMID:
17122134
15.

The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative.

Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA.

Curr Eye Res. 1994 Jul;13(7):513-22.

PMID:
7523029
16.

Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.

Nagae T, Aizawa K, Uchimura N, Tani D, Abe M, Fujishima K, Wilson SE, Ishimaru S.

Lasers Surg Med. 2001;28(4):381-8.

PMID:
11344521
17.

Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies.

Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH.

Ophthalmic Surg Lasers. 1998 Aug;29(8):663-8.

PMID:
9715492
18.

[Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].

Mori K, Ohta M, Sano A, Yoneya S, Sonoda M, Kaneda A, Sato Y.

Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):134-40. Japanese.

PMID:
9124093
19.

Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes.

Schlötzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U.

Graefes Arch Clin Exp Ophthalmol. 2002 Sep;240(9):748-57. Epub 2002 Aug 27.

PMID:
12271373
20.

Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes.

Berdugo M, Bejjani RA, Valamanesh F, Savoldelli M, Jeanny JC, Blanc D, Ficheux H, Scherz A, Salomon Y, BenEzra D, Behar-Cohen F.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1633-44. doi: 10.1167/iovs.07-0767.

PMID:
18385085

Supplemental Content

Support Center